Skip to main content
SpringerLink
Log in

Warnungen von Behörden bestätigt

Gabapentinoide können COPD-Patienten gefährlich werden

  • Aktuelle Medizin
  • Published:
MMW - Fortschritte der Medizin Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Springer Medizin Verlag GmbH, Aschauer Str. 30, 81549, München, Germany

    Robert Bublak

Authors
  1. Robert Bublak
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bublak, R. Gabapentinoide können COPD-Patienten gefährlich werden. MMW Fortschr Med 166, 20–21 (2024). https://doi.org/10.1007/s15006-024-3608-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-024-3608-x

Search

Navigation